AstraZeneca's Buying Spree Bolsters Pipeline

Trigger-happy AstraZeneca  (NYSE: AZN  ) is done waiting for home-grown talent to develop. In recent weeks, the Big Pharma laggard has acquired Omthera  (NASDAQ: OMTH  ) and Pearl Therapeutics. These acquisitions instantly inject one promising late-stage drug into the  pipeline, one drug facing regulatory approval into the product mix, and a few others in earlier stages of development. The company has thrust itself into competing in two major markets virtually overnight. This is certainly a welcomed sight for investors, who have experienced their fair share of disappointment in recent quarters. The moves don't put AstraZeneca on the same level as more successful peers, but it is a great start to getting back on the right track. In the following video, Fool contributor Maxx Chatsko explains what the moves mean for investors. 

Obamacare will undoubtedly have far-reaching effects. The Motley Fool's new free report, "Everything You Need to Know About Obamacare," lets you know how your health insurance, your taxes, and your portfolio could be affected. Click here to read more. 


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2491233, ~/Articles/ArticleHandler.aspx, 9/22/2014 2:40:24 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement